Home
Mette Pernille Myklebust's picture

Mette Pernille Myklebust

Staff Engineer
  • E-mailMette.Myklebust@uib.no
  • Phone+47 55 97 75 65
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Myklebust, Mette Pernille; Rosenlund, Nina Benedikte; Gjengstø, Peder; Bercea, Bogdan Stefan; Karlsdottir, Åsa; Brydøy, Marianne; Dahl, Olav. 2019. Quantitative PCR Measurement of miR-371a-3p and miR-372-p Is Influenced by Hemolysis. Frontiers in Genetics. 1-9.
  • Jacob, Havjin; Stanisavljevic, Luka; Storli, Kristian Eeg; Hestetun, Kjersti Elvestad; Dahl, Olav; Myklebust, Mette Pernille. 2018. A four-microRNA classifier as a novel prognostic marker for tumor recurrence in stage II colon cancer. Scientific Reports. 1-9.
  • Jacob, Havjin; Stanisavljevic, Luka; Storli, Kristian Eg; Hestetun, Kjersti Elvestad; Dahl, Olav; Myklebust, Mette Pernille. 2017. Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer. OncoTarget. 87837-87847.
  • Stanisavljevic, Luka; Myklebust, Mette Pernille; Leh, Sabine Maria; Dahl, Olav. 2016. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer. Acta Oncologica. 1425-1433.
  • Hestetun, Kjersti Elvestad; Brydøy, Marianne; Myklebust, Mette Pernille; Dahl, Olav. 2015. Nuclear maspin expression as a predictive marker for fluorouracil treatment response in colon cancer. Acta Oncologica. 470-479.
  • Stanisavljevic, Luka; Assmus, Jörg; Storli, Kristian Eg; Leh, Sabine Maria; Dahl, Olav; Myklebust, Mette Pernille. 2015. CXCR4, CXCL12 and the relative CXCL12-CXCR4 expression as prognostic factors in colon cancer. Tumour Biology. 1-12.
  • Myklebust, Mette Pernille; Li, Zhiping; Tran, Thai H.; Rui, Hallgeir; Knudsen, Erik S.; Elsaleh, Hany; Fluge, Øystein; Vonen, Barthold; Myrvold, Helge Elliot; Leh, Sabine; Tveit, Magne Kjell; Pestell, Richard G.; Dahl, Olav. 2012. Expression of cyclin D1a and D1b as predictive factors for treatment response in colorectal cancer. British Journal of Cancer. 1684-1691.
  • Myklebust, Mette Pernille; Fluge, Øystein; Immervoll, Heike ; Skarstein, Arne; Balteskard, Lise; Bruland, Ove; Dahl, Olav. 2012. Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients. British Journal of Cancer. 756-762.
  • Myklebust, Mette Pernille; Bruland, Ove; Fluge, Øystein; Skarstein, Arne; Balteskard, Lise; Dahl, Olav. 2011. MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer. British Journal of Cancer. 1719-1725.
  • Bruland, Ove; Fluge, Øystein; Immervoll, Heike; Balteskard, Lise; Myklebust, Mette Pernille; Skarstein, Arne; Dahl, Olav. 2008. Gene expression reveals two distinct groups of anal carcinomas with clinical implications. British Journal of Cancer. 1264-1273.
Doctoral dissertation
  • Myklebust, Mette Pernille. 2012. Molecular markers of anal cancer and colorectal cancer. A study of microRNAs, desmosomal cadherins and cyclin D1 isoforms.

More information in national current research information system (CRIStin)